ENTELLUS MEDICAL INC·4

Sep 14, 4:08 PM ET

PAIDOSH STEPHEN R 4

4 · ENTELLUS MEDICAL INC · Filed Sep 14, 2017

Insider Transaction Report

Form 4
Period: 2017-09-13
PAIDOSH STEPHEN R
VICE PRESIDENT, OPERATIONS
Transactions
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2017-09-13$1.40/sh+25,000$35,00032,500 total
  • Sale

    Common Stock, $0.001 par value

    2017-09-13$17.54/sh25,000$438,5007,500 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-09-13$1.40/sh25,000$35,0000 total
    Exercise: $1.40Exp: 2017-12-17Common Stock (25,000 underlying)
Footnotes (3)
  • [F1]Includes 7,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50 to $17.60, inclusive. The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  • [F3]The option became fully vested on December 17, 2011.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT